{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T12:16:39Z","timestamp":1785845799094,"version":"3.56.0"},"publisher-location":"Cham","reference-count":141,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030506209","type":"print"},{"value":"9783030506216","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-50621-6_9","type":"book-chapter","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T12:02:40Z","timestamp":1599480160000},"page":"203-222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Drugging the Phosphoinositide 3-Kinase (PI3K) and Phosphatidylinositol 4-Kinase (PI4K) Family of Enzymes for Treatment of Cancer, Immune Disorders, and Viral\/Parasitic Infections"],"prefix":"10.1007","author":[{"given":"Jacob A.","family":"McPhail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,8]]},"reference":[{"issue":"3","key":"9_CR1","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1152\/physrev.00028.2012","volume":"93","author":"T Balla","year":"2013","unstructured":"Balla T (2013) Phosphoinositides: tiny lipids with giant impact on cell regulation. Physiol Rev 93(3):1019\u20131137","journal-title":"Physiol Rev"},{"issue":"7112","key":"9_CR2","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nature05185","volume":"443","author":"G Di Paolo","year":"2006","unstructured":"Di Paolo G, De Camilli P (2006) Phosphoinositides in cell regulation and membrane dynamics. Nature 443(7112):651\u2013657","journal-title":"Nature"},{"issue":"7","key":"9_CR3","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1073\/pnas.81.7.2117","volume":"81","author":"Y Sugimoto","year":"1984","unstructured":"Sugimoto Y, Whitman M, Cantley LC, Erikson RL (1984) Evidence that the Rous sarcoma virus transforming gene product phosphorylates phosphatidylinositol and diacylglycerol. Proc Natl Acad Sci U S A 81(7):2117\u20132121","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6016","key":"9_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/315239a0","volume":"315","author":"M Whitman","year":"1985","unstructured":"Whitman M, Kaplan DR, Schaffhausen B, Cantley L, Roberts TM (1985) Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation. Nature 315(6016):239\u2013242","journal-title":"Nature"},{"issue":"1","key":"9_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0092-8674(89)90182-7","volume":"57","author":"KR Auger","year":"1989","unstructured":"Auger KR, Serunian LA, Soltoff SP, Libby P, Cantley LC (1989) PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell 57(1):167\u2013175","journal-title":"Cell"},{"issue":"6382","key":"9_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/358157a0","volume":"358","author":"PT Hawkins","year":"1992","unstructured":"Hawkins PT, Jackson TR, Stephens LR (1992) Platelet-derived growth factor stimulates synthesis of PtdIns(3,4,5)P3 by activating a PtdIns(4,5)P2 3-OH kinase. Nature 358(6382):157\u2013159","journal-title":"Nature"},{"issue":"6321","key":"9_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/351033a0","volume":"351","author":"LR Stephens","year":"1991","unstructured":"Stephens LR, Hughes KT, Irvine RF (1991) Pathway of phosphatidylinositol(3,4,5)-trisphosphate synthesis in activated neutrophils. Nature 351(6321):33\u201339","journal-title":"Nature"},{"issue":"4","key":"9_CR8","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1073\/pnas.87.4.1411","volume":"87","author":"NB Ruderman","year":"1990","unstructured":"Ruderman NB, Kapeller R, White MF, Cantley LC (1990) Activation of phosphatidylinositol 3-kinase by insulin. Proc Natl Acad Sci U S A 87(4):1411\u20131415","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"9_CR9","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1002\/j.1460-2075.1992.tb05426.x","volume":"11","author":"JM Backer","year":"1992","unstructured":"Backer JM, Myers MG, Shoelson SE, Chin DJ, Sun XJ, Miralpeix M et al (1992) Phosphatidylinositol 3\u2032-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J 11(9):3469\u20133479","journal-title":"EMBO J"},{"issue":"3","key":"9_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nrm3290","volume":"13","author":"B Vanhaesebroeck","year":"2012","unstructured":"Vanhaesebroeck B, Stephens L, Hawkins P (2012) PI3K signalling: the path to discovery and understanding. Nat Rev Mol Cell Biol [Internet] 13(3):195\u2013203","journal-title":"Nat Rev Mol Cell Biol [Internet]"},{"issue":"5573","key":"9_CR11","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","volume":"296","author":"L Cantley","year":"2002","unstructured":"Cantley L (2002) The phosphoinositide 3-kinase pathway. Science 296(5573):1655\u20131657","journal-title":"Science"},{"issue":"2","key":"9_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.tibs.2014.12.003","volume":"40","author":"JE Burke","year":"2015","unstructured":"Burke JE, Williams RL (2015) Synergy in activating class I PI3Ks. Trends Biochem Sci 40(2):88\u2013100","journal-title":"Trends Biochem Sci"},{"issue":"4","key":"9_CR13","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","volume":"170","author":"DA Fruman","year":"2017","unstructured":"Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT (2017) The PI3K pathway in human disease. Cell 170(4):605\u2013635","journal-title":"Cell"},{"issue":"3","key":"9_CR14","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.molcel.2016.12.028","volume":"65","author":"M Ebner","year":"2017","unstructured":"Ebner M, Lu\u010di\u0107 I, Leonard TA, Yudushkin I (2017) PI(3,4,5)P3 engagement restricts Akt activity to cellular membranes. Mol Cell 65(3):416\u2013416","journal-title":"Mol Cell"},{"key":"9_CR15","first-page":"6742","volume":"10","author":"B Bilanges","year":"2019","unstructured":"Bilanges B, Posor Y, Vanhaesebroeck B (2019) PI3K isoforms in cell signalling and vesicle trafficking. Nat Rev Mol Cell Biol 10:6742","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"9_CR16","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.cell.2006.03.035","volume":"125","author":"Z Knight","year":"2006","unstructured":"Knight Z, Gonzalez B, Feldman M, Zunder E, Goldenberg D, Williams O et al (2006) A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell 125(4):733\u2013747","journal-title":"Cell"},{"issue":"5","key":"9_CR17","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nm1232","volume":"11","author":"S Jackson","year":"2005","unstructured":"Jackson S, Schoenwaelder S, Goncalves I, Nesbitt W, Yap C, Wright C et al (2005) PI 3-kinase p110beta: a new target for antithrombotic therapy. Nat Med 11(5):507\u2013514","journal-title":"Nat Med"},{"issue":"5583","key":"9_CR18","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1126\/science.1073560","volume":"297","author":"K Okkenhaug","year":"2002","unstructured":"Okkenhaug K, Bilancio A, Farjot G, Priddle H, Sancho S, Peskett E et al (2002) Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science [Internet] 297(5583):1031\u20131034","journal-title":"Science [Internet]"},{"issue":"8","key":"9_CR19","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1182\/blood-2007-04-086751","volume":"110","author":"H Ji","year":"2007","unstructured":"Ji H, Rintelen F, Waltzinger C, Bertschy Meier D, Bilancio A, Pearce W et al (2007) Inactivation of PI3Kgamma and PI3Kdelta distorts T-cell development and causes multiple organ inflammation. Blood 110(8):2940\u20132947","journal-title":"Blood"},{"issue":"10","key":"9_CR20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.it.2008.07.004","volume":"29","author":"M-S Kim","year":"2008","unstructured":"Kim M-S, R\u00e5dinger M, Gilfillan AM (2008) The multiple roles of phosphoinositide 3-kinase in mast cell biology. Trends Immunol 29(10):493\u2013501","journal-title":"Trends Immunol"},{"issue":"5455","key":"9_CR21","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1126\/science.287.5455.1046","volume":"287","author":"Z Li","year":"2000","unstructured":"Li Z, Jiang H, Xie W, Zhang Z, Smrcka AV, Wu D (2000) Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. Science 287(5455):1046\u20131049","journal-title":"Science"},{"issue":"1","key":"9_CR22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/ncb1517","volume":"9","author":"G Ferguson","year":"2007","unstructured":"Ferguson G, Milne L, Kulkarni S, Sasaki T, Walker S, Andrews S et al (2007) PI(3)Kgamma has an important context-dependent role in neutrophil chemokinesis. Nat Cell Biol 9(1):86\u201391","journal-title":"Nat Cell Biol"},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1146\/annurev-immunol-032712-095946","volume":"31","author":"K Okkenhaug","year":"2013","unstructured":"Okkenhaug K (2013) Signaling by the phosphoinositide 3-kinase family in immune cells. Annu Rev Immunol 31:675\u2013704","journal-title":"Annu Rev Immunol"},{"issue":"6759","key":"9_CR24","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/46319","volume":"402","author":"EH Walker","year":"1999","unstructured":"Walker EH, Perisic O, Ried C, Stephens L, Williams RL (1999) Structural insights into phosphoinositide 3-kinase catalysis and signalling. Nature 402(6759):313\u2013320","journal-title":"Nature"},{"issue":"4","key":"9_CR25","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S1097-2765(05)00089-4","volume":"6","author":"EH Walker","year":"2000","unstructured":"Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, Wymann MP et al (2000) Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell [Internet] 6(4):909\u2013919","journal-title":"Mol Cell [Internet]"},{"issue":"5857","key":"9_CR26","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1126\/science.1150799","volume":"318","author":"C Huang","year":"2007","unstructured":"Huang C, Mandelker D, Schmidt-Kittler O, Samuels Y, Velculescu V, Kinzler K et al (2007) The structure of a human p110alpha\/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations. Science 318(5857):1744\u20131748","journal-title":"Science"},{"issue":"5","key":"9_CR27","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.molcel.2011.01.026","volume":"41","author":"X Zhang","year":"2011","unstructured":"Zhang X, Vadas O, Perisic O, Anderson KE, Clark J, Hawkins PT et al (2011) Structure of lipid kinase p110b\/p85b elucidates an unusual SH2-domain-mediated inhibitory mechanism. Mol Cell [Internet] 41(5):567\u2013578","journal-title":"Mol Cell [Internet]"},{"issue":"6187","key":"9_CR28","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1126\/science.1253397","volume":"344","author":"JE Burke","year":"2014","unstructured":"Burke JE, Inglis AJ, Perisic O, Masson GR, McLaughlin SH, Rutaganira F et al (2014) Structures of PI4KIII\u03b2 complexes show simultaneous recruitment of Rab11 and its effectors. Science 344(6187):1035\u20131038","journal-title":"Science"},{"issue":"2","key":"9_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nchembio.293","volume":"6","author":"A Berndt","year":"2010","unstructured":"Berndt A, Miller S, Williams O, Le DD, Houseman BT, Pacold JI et al (2010) The p110 delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitors. Nat Chem Biol 6(2):117\u2013124","journal-title":"Nat Chem Biol"},{"issue":"52","key":"9_CR30","doi-asserted-by":"publisher","first-page":"13720","DOI":"10.1073\/pnas.1718471115","volume":"114","author":"JA Lees","year":"2017","unstructured":"Lees JA, Zhang Y, Oh MS, Schauder CM, Yu X, Baskin JM et al (2017) Architecture of the human PI4KIII\u03b1 lipid kinase complex. Proc Natl Acad Sci U S A 114(52):13720\u201313725","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"195","key":"9_CR31","first-page":"1","volume":"4","author":"O Vadas","year":"2011","unstructured":"Vadas O, Burke JE, Zhang X, Berndt A, Williams RL (2011) Structural basis for activation and inhibition of class I phosphoinositide 3-kinases. Sci Signal [Internet] 4(195):1\u201313","journal-title":"Sci Signal [Internet]"},{"issue":"5973","key":"9_CR32","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1126\/science.1184429","volume":"327","author":"S Miller","year":"2010","unstructured":"Miller S, Tavshanjian B, Oleksy A, Perisic O, Houseman B, Shokat K et al (2010) Shaping development of autophagy inhibitors with the structure of the lipid kinase Vps34. Science 327(5973):1638\u20131642","journal-title":"Science"},{"issue":"5835","key":"9_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1126\/science.1135394","volume":"317","author":"N Miled","year":"2007","unstructured":"Miled N, Yan Y, Hon W-C, Perisic O, Zvelebil M, Inbar Y et al (2007) Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit. Science 317(5835):239\u2013242","journal-title":"Science"},{"issue":"46","key":"9_CR34","doi-asserted-by":"publisher","first-page":"30199","DOI":"10.1074\/jbc.273.46.30199","volume":"273","author":"J Yu","year":"1998","unstructured":"Yu J, Wjasow C, Backer JM (1998) Regulation of the p85\/p110alpha phosphatidylinositol 3\u2032-kinase. Distinct roles for the n-terminal and c-terminal SH2 domains. J Biol Chem 273(46):30199\u201330203","journal-title":"J Biol Chem"},{"issue":"3","key":"9_CR35","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1128\/MCB.18.3.1379","volume":"18","author":"J Yu","year":"1998","unstructured":"Yu J, Zhang Y, McIlroy J, Rordorf-Nikolic T, Orr GA, Backer JM (1998) Regulation of the p85\/p110 phosphatidylinositol 3\u2032-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit. Mol Cell Biol 18(3):1379\u20131387","journal-title":"Mol Cell Biol"},{"issue":"5","key":"9_CR36","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/0092-8674(93)90404-E","volume":"72","author":"Z Songyang","year":"1993","unstructured":"Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG et al (1993) SH2 domains recognize specific phosphopeptide sequences. Cell 72(5):767\u2013778","journal-title":"Cell"},{"issue":"40","key":"9_CR37","doi-asserted-by":"publisher","first-page":"16996","DOI":"10.1073\/pnas.0908444106","volume":"106","author":"D Mandelker","year":"2009","unstructured":"Mandelker D, Gabelli SB, Schmidt-Kittler O, Zhu J, Cheong I, Huang C-H et al (2009) A frequent kinase domain mutation that changes the interaction between PI3Kalpha and the membrane. Proc Natl Acad Sci U S A 106(40):16996\u201317001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"9_CR38","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.cub.2005.02.020","volume":"15","author":"S Suire","year":"2005","unstructured":"Suire S, Coadwell J, Ferguson GJ, Davidson K, Hawkins P, Stephens L (2005) p84, a new Gbetagamma-activated regulatory subunit of the type IB phosphoinositide 3-kinase p110gamma. Curr Biol [Internet] 15(6):566\u2013570","journal-title":"Curr Biol [Internet]"},{"issue":"1","key":"9_CR39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0092-8674(00)80187-7","volume":"89","author":"LR Stephens","year":"1997","unstructured":"Stephens LR, Eguinoa A, Erdjument-Bromage H, Lui M, Cooke F, Coadwell J et al (1997) The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101. Cell 89(1):105\u2013114","journal-title":"Cell"},{"issue":"48","key":"9_CR40","doi-asserted-by":"publisher","first-page":"20312","DOI":"10.1073\/pnas.0905506106","volume":"106","author":"B Kurig","year":"2009","unstructured":"Kurig B, Shymanets A, Bohnacker T, Prajwal, Brock C, Ahmadian MR et al (2009) Ras is an indispensable coregulator of the class IB phosphoinositide 3-kinase p87\/p110gamma. Proc Natl Acad Sci U S A [Internet] 106(48):20312\u201320317","journal-title":"Proc Natl Acad Sci U S A [Internet]"},{"issue":"41","key":"9_CR41","doi-asserted-by":"publisher","first-page":"29311","DOI":"10.1074\/jbc.274.41.29311","volume":"274","author":"U Maier","year":"1999","unstructured":"Maier U, Babich A, Nurnberg B (1999) Roles of non-catalytic subunits in gbetagamma-induced activation of class I phosphoinositide 3-kinase isoforms beta and gamma. J Biol Chem 274(41):29311\u201329317","journal-title":"J Biol Chem"},{"issue":"6","key":"9_CR42","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S0092-8674(00)00196-3","volume":"103","author":"ME Pacold","year":"2000","unstructured":"Pacold ME, Suire S, Perisic O, Lara-Gonzalez S, Davis CT, Walker EH et al (2000) Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. Cell [Internet] 103(6):931\u2013943","journal-title":"Cell [Internet]"},{"issue":"29","key":"9_CR43","doi-asserted-by":"publisher","first-page":"12256","DOI":"10.1074\/jbc.M117.789263","volume":"292","author":"BD Siempelkamp","year":"2017","unstructured":"Siempelkamp BD, Rathinaswamy MK, Jenkins ML, Burke JE (2017) Molecular mechanism of activation of class IA phosphoinositide 3-kinases (PI3Ks) by membrane-localized HRas. J Biol Chem 292(29):12256\u201312266","journal-title":"J Biol Chem"},{"issue":"5","key":"9_CR44","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.cell.2013.04.031","volume":"153","author":"R Fritsch","year":"2013","unstructured":"Fritsch R, de Krijger I, Fritsch K, George R, Reason B, Kumar MS et al (2013) RAS and RHO families of GTPases directly regulate distinct phosphoinositide 3-kinase isoforms. Cell 153(5):1050\u20131063","journal-title":"Cell"},{"issue":"5","key":"9_CR45","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.molcel.2018.08.005","volume":"71","author":"JE Burke","year":"2018","unstructured":"Burke JE (2018) Structural basis for regulation of phosphoinositide kinases and their involvement in human disease. Mol Cell 71(5):653\u2013673","journal-title":"Mol Cell"},{"issue":"1","key":"9_CR46","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1042\/BST20150219","volume":"44","author":"GL Dornan","year":"2016","unstructured":"Dornan GL, McPhail JA, Burke JE (2016) Type III phosphatidylinositol 4 kinases: structure, function, regulation, signalling and involvement in disease. Biochem Soc Trans 44(1):260\u2013266","journal-title":"Biochem Soc Trans"},{"key":"9_CR47","doi-asserted-by":"crossref","unstructured":"Boura E, Nencka R (2015) Phosphatidylinositol 4-kinases: function, structure, and inhibition. Exp Cell Res 14","DOI":"10.1016\/j.yexcr.2015.03.028"},{"issue":"5138","key":"9_CR48","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.8248783","volume":"262","author":"CA Flanagan","year":"1993","unstructured":"Flanagan CA, Schnieders EA, Emerick AW, Kunisawa R, Admon A, Thorner J (1993) Phosphatidylinositol 4-kinase\u00a0\u2013 gene structure and requirement for yeast-cell viability. Science 262(5138):1444\u20131448","journal-title":"Science"},{"key":"9_CR49","doi-asserted-by":"publisher","first-page":"18358","DOI":"10.1074\/jbc.272.29.18358","volume":"272","author":"T Balla","year":"1997","unstructured":"Balla T, Downing GJ, Jaffe H, Kim S, Zolyomi A, Catt KJ (1997) Isolation and molecular cloning of wortmannin-sensitive bovine type III phosphatidylinositol 4-kinases. J Biol Chem 272:18358\u201318366","journal-title":"J Biol Chem"},{"issue":"7","key":"9_CR50","doi-asserted-by":"publisher","first-page":"4384","DOI":"10.1074\/jbc.272.7.4384","volume":"272","author":"R Meyers","year":"1997","unstructured":"Meyers R, Cantley LC (1997) Cloning and characterization of a wortmannin-sensitive human phosphatidylinositol 4-kinase. J Biol Chem 272(7):4384\u20134390","journal-title":"J Biol Chem"},{"issue":"6","key":"9_CR51","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1083\/jcb.200908107","volume":"187","author":"G Polevoy","year":"2009","unstructured":"Polevoy G, Wei H-C, Wong R, Szentpetery Z, Kim YJ, Goldbach P et al (2009) Dual roles for the Drosophila PI 4-kinase four wheel drive in localizing Rab11 during cytokinesis. J Cell Biol 187(6):847\u2013858","journal-title":"J Cell Biol"},{"issue":"5","key":"9_CR52","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/12993","volume":"1","author":"A Godi","year":"1999","unstructured":"Godi A, Pertile P, Meyers R, Marra P, Di Tullio G, Iurisci C et al (1999) ARF mediates recruitment of PtdIns-4-OH kinase-beta and stimulates synthesis of PtdIns(4,5)P2 on the Golgi complex. Nat Cell Biol 1(5):280\u2013287","journal-title":"Nat Cell Biol"},{"issue":"47","key":"9_CR53","doi-asserted-by":"publisher","first-page":"36369","DOI":"10.1074\/jbc.M604935200","volume":"281","author":"B T\u00f3th","year":"2006","unstructured":"T\u00f3th B, Balla A, Ma H, Knight ZA, Shokat KM, Balla T (2006) Phosphatidylinositol 4-kinase IIIbeta regulates the transport of ceramide between the endoplasmic reticulum and Golgi. J Biol Chem 281(47):36369\u201336377","journal-title":"J Biol Chem"},{"issue":"2","key":"9_CR54","doi-asserted-by":"publisher","first-page":"e00098","DOI":"10.1128\/mBio.00098-13","volume":"4","author":"AL Greninger","year":"2013","unstructured":"Greninger AL, Knudsen GM, Betegon M, Burlingame AL, DeRisi JL (2013) ACBD3 interaction with TBC1 domain 22 protein is differentially affected by enteroviral and kobuviral 3A protein binding. MBio 4(2):e00098\u2013e00013","journal-title":"MBio"},{"issue":"3","key":"9_CR55","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/emboj.2011.429","volume":"31","author":"J Sasaki","year":"2012","unstructured":"Sasaki J, Ishikawa K, Arita M, Taniguchi K (2012) ACBD3-mediated recruitment of PI4KB to picornavirus RNA replication sites. EMBO J 31(3):754\u2013766","journal-title":"EMBO J"},{"issue":"5","key":"9_CR56","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.cell.2010.03.050","volume":"141","author":"N-Y Hsu","year":"2010","unstructured":"Hsu N-Y, Ilnytska O, Belov G, Santiana M, Chen Y-H, Takvorian PM et al (2010) Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell 141(5):799\u2013811","journal-title":"Cell"},{"issue":"7658","key":"9_CR57","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature22337","volume":"546","author":"UH Manjunatha","year":"2017","unstructured":"Manjunatha UH, Vinayak S, Zambriski JA, Chao AT, Sy T, Noble CG et al (2017) A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis. Nature 546(7658):376\u2013380","journal-title":"Nature"},{"issue":"387","key":"9_CR58","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aad9735","volume":"9","author":"T Paquet","year":"2017","unstructured":"Paquet T, Le Manach C, Cabrera DG, Younis Y, Henrich PP, Abraham TS et al (2017) Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase. Sci Transl Med 9(387):eaad9735","journal-title":"Sci Transl Med"},{"issue":"7625","key":"9_CR59","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature19804","volume":"538","author":"N Kato","year":"2016","unstructured":"Kato N, Comer E, Sakata-Kato T, Sharma A, Sharma M, Maetani M et al (2016) Diversity-oriented synthesis yields novel multistage antimalarial inhibitors. Nature 538(7625):344\u2013349","journal-title":"Nature"},{"issue":"7479","key":"9_CR60","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nature12782","volume":"504","author":"CW McNamara","year":"2013","unstructured":"McNamara CW, Lee MCS, Lim CS, Lim SH, Roland J, Nagle A et al (2013) Targeting Plasmodium PI(4)K to eliminate malaria. Nature 504(7479):248\u2013253","journal-title":"Nature"},{"issue":"7465","key":"9_CR61","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature12423","volume":"501","author":"G D\u2019Angelo","year":"2013","unstructured":"D\u2019Angelo G, Uemura T, Chuang C-C, Polishchuk E, Santoro M, Ohvo-Rekil\u00e4 H et al (2013) Vesicular and non-vesicular transport feed distinct glycosylation pathways in the Golgi. Nature 501(7465):116\u2013120","journal-title":"Nature"},{"issue":"4","key":"9_CR62","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.cell.2013.09.056","volume":"155","author":"B Mesmin","year":"2013","unstructured":"Mesmin B, Bigay J, Moser von Filseck J, Lacas-Gervais S, Drin G, Antonny B (2013) A four-step cycle driven by PI(4)P hydrolysis directs sterol\/PI(4)P exchange by the ER-Golgi tether OSBP. Cell 155(4):830\u2013843","journal-title":"Cell"},{"issue":"5","key":"9_CR63","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.devcel.2019.05.038","volume":"50","author":"J Rahajeng","year":"2019","unstructured":"Rahajeng J, Kuna RS, Makowski SL, Tran TTT, Buschman MD, Li S et al (2019) Efficient Golgi forward trafficking requires GOLPH3-driven, PI4P-dependent membrane curvature. Dev Cell 50(5):573\u2013575","journal-title":"Dev Cell"},{"issue":"2","key":"9_CR64","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.cell.2009.07.052","volume":"139","author":"HC Dippold","year":"2009","unstructured":"Dippold HC, Ng MM, Farber-Katz SE, Lee S-K, Kerr ML, Peterman MC et al (2009) GOLPH3 bridges phosphatidylinositol-4- phosphate and actomyosin to stretch and shape the Golgi to promote budding. Cell 139(2):337\u2013351","journal-title":"Cell"},{"issue":"4","key":"9_CR65","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1091\/mbc.e03-12-0862","volume":"15","author":"P de Graaf","year":"2004","unstructured":"de Graaf P, Zwart WT, van Dijken RAJ, Deneka M, Schulz TKF, Geijsen N et al (2004) Phosphatidylinositol 4-kinasebeta is critical for functional association of rab11 with the Golgi complex. Mol Biol Cell 15(4):2038\u20132047","journal-title":"Mol Biol Cell"},{"issue":"1","key":"9_CR66","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.str.2016.11.016","volume":"25","author":"JA McPhail","year":"2017","unstructured":"McPhail JA, Ottosen EH, Jenkins ML, Burke JE (2017) The molecular basis of Aichi virus 3A protein activation of phosphatidylinositol 4 kinase III\u03b2, PI4KB, through ACBD3. Structure 25(1):121\u2013131","journal-title":"Structure"},{"issue":"1","key":"9_CR67","doi-asserted-by":"publisher","first-page":"23641","DOI":"10.1038\/srep23641","volume":"6","author":"M Klima","year":"2016","unstructured":"Klima M, T\u00f3th DJ, Hexnerova R, Baumlov\u00e1 A, Chalupsk\u00e1 D, Tykvart J et al (2016) Structural insights and in vitro reconstitution of membrane targeting and activation of human PI4KB by the ACBD3 protein. Sci Rep 6(1):23641","journal-title":"Sci Rep"},{"issue":"8","key":"9_CR68","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1091\/mbc.e11-06-0553","volume":"23","author":"M Jovic","year":"2012","unstructured":"Jovic M, Kean MJ, Szentpetery Z, Polevoy G, Gingras A-C, Brill JA et al (2012) Two phosphatidylinositol 4-kinases control lysosomal delivery of the Gaucher disease enzyme, \u03b2-glucocerebrosidase. Mol Biol Cell 23(8):1533\u20131545","journal-title":"Mol Biol Cell"},{"key":"9_CR69","doi-asserted-by":"crossref","unstructured":"Chalupsk\u00e1 D, Eisenreichova A, R\u00f3zycki B, Rezabkova L, Humpolickova J, Klima M et al (2017) Structural analysis of phosphatidylinositol 4-kinase III\u03b2 (PI4KB)\u00a0\u2013 14-3-3 protein complex reveals internal flexibility and explains 14-3-3 mediated protection from degradation in vitro. J Struct Biol 31","DOI":"10.1016\/j.jsb.2017.08.006"},{"issue":"4","key":"9_CR70","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/ncb2445","volume":"14","author":"C Valente","year":"2012","unstructured":"Valente C, Turacchio G, Mariggi\u00f2 S, Pagliuso A, Gaibisso R, Di Tullio G et al (2012) A 14-3-3\u03b3 dimer-based scaffold bridges CtBP1-S\/BARS to PI(4)KIII\u03b2 to regulate post-Golgi carrier formation. Nat Cell Biol 14(4):343\u2013354","journal-title":"Nat Cell Biol"},{"issue":"9","key":"9_CR71","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/ncb1289","volume":"7","author":"A Hausser","year":"2005","unstructured":"Hausser A, Storz P, M\u00e4rtens S, Link G, Toker A, Pfizenmaier K (2005) Protein kinase D regulates vesicular transport by phosphorylating and activating phosphatidylinositol-4 kinase IIIbeta at the Golgi complex. Nat Cell Biol 7(9):880\u2013886","journal-title":"Nat Cell Biol"},{"issue":"11","key":"9_CR72","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nchembio835","volume":"2","author":"KE Ile","year":"2006","unstructured":"Ile KE, Schaaf G, Bankaitis VA (2006) Phosphatidylinositol transfer proteins and cellular nanoreactors for lipid signaling. Nat Chem Biol 2(11):576\u2013583","journal-title":"Nat Chem Biol"},{"issue":"2","key":"9_CR73","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.molcel.2007.11.026","volume":"29","author":"G Schaaf","year":"2008","unstructured":"Schaaf G, Ortlund EA, Tyeryar KR, Mousley CJ, Ile KE, Garrett TA et al (2008) Functional anatomy of phospholipid binding and regulation of phosphoinositide homeostasis by proteins of the sec14 superfamily. Mol Cell 29(2):191\u2013206","journal-title":"Mol Cell"},{"issue":"7","key":"9_CR74","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.tibs.2012.03.004","volume":"37","author":"N Altan-Bonnet","year":"2012","unstructured":"Altan-Bonnet N, Balla T (2012) Phosphatidylinositol 4-kinases: hostages harnessed to build panviral replication platforms. Trends Biochem Sci 37(7):293\u2013302","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"9_CR75","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1128\/mBio.02742-18","volume":"10","author":"H Lyoo","year":"2019","unstructured":"Lyoo H, van der Schaar HM, Dorobantu CM, Rabouw HH, Strating JRPM, van Kuppeveld FJM (2019) ACBD3 is an essential pan-enterovirus host factor that mediates the interaction between viral 3A protein and cellular protein PI4KB. Racaniello VR, Racaniello VR (eds). MBio 10(1):282","journal-title":"MBio"},{"issue":"2","key":"9_CR76","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.str.2016.11.021","volume":"25","author":"M Klima","year":"2017","unstructured":"Klima M, Chalupsk\u00e1 D, R\u00f3zycki B, Humpolickova J, Rezabkova L, Silhan J et al (2017) Kobuviral non-structural 3A proteins act as molecular harnesses to Hijack the host ACBD3 protein. Structure 25(2):219\u2013230","journal-title":"Structure"},{"issue":"7","key":"9_CR77","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.tim.2016.02.017","volume":"24","author":"HM van der Schaar","year":"2016","unstructured":"van der Schaar HM, Dorobantu CM, Albulescu L, Strating JRPM, van Kuppeveld FJM (2016) Fat(al) attraction: picornaviruses usurp lipid transfer at membrane contact sites to create replication organelles. Trends Microbiol 24(7):535\u2013546","journal-title":"Trends Microbiol"},{"issue":"12","key":"9_CR78","doi-asserted-by":"publisher","first-page":"6586","DOI":"10.1128\/JVI.00208-14","volume":"88","author":"K Ishikawa-Sasaki","year":"2014","unstructured":"Ishikawa-Sasaki K, Sasaki J, Taniguchi K (2014) A complex comprising phosphatidylinositol 4-kinase III\u03b2, ACBD3, and Aichi virus proteins enhances phosphatidylinositol 4-phosphate synthesis and is critical for formation of the viral replication complex. J Virol 88(12):6586\u20136598","journal-title":"J Virol"},{"issue":"20","key":"9_CR79","doi-asserted-by":"publisher","first-page":"11031","DOI":"10.1128\/JVI.00304-13","volume":"87","author":"F T\u00e9oul\u00e9","year":"2013","unstructured":"T\u00e9oul\u00e9 F, Brisac C, Pelletier I, Vidalain P-O, J\u00e9gouic S, Mirabelli C et al (2013) The Golgi protein ACBD3, an interactor for poliovirus protein 3A, modulates poliovirus replication. J Virol 87(20):11031\u201311046","journal-title":"J Virol"},{"issue":"5670","key":"9_CR80","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1126\/science.1096502","volume":"304","author":"Y Samuels","year":"2004","unstructured":"Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S et al (2004) High frequency of mutations of the PIK3CA gene in human cancers. Science 304(5670):554","journal-title":"Science"},{"issue":"12","key":"9_CR81","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1158\/0008-5472.CAN-11-0549","volume":"71","author":"ME Urick","year":"2011","unstructured":"Urick ME, Rudd ML, Godwin AK, Sgroi D, Merino M, Bell DW (2011) PIK3R1 (p85\u03b1) is somatically mutated at high frequency in primary endometrial cancer. Cancer Res 71(12):4061\u20134067","journal-title":"Cancer Res"},{"issue":"6","key":"9_CR82","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ccr.2009.10.016","volume":"16","author":"BS Jaiswal","year":"2009","unstructured":"Jaiswal BS, Janakiraman V, Kljavin NM, Chaudhuri S, Stern HM, Wang W et al (2009) Somatic mutations in p85a promote tumorigenesis through class IA PI3K activation. Cancer Cell [Internet] 16(6):463\u2013474","journal-title":"Cancer Cell [Internet]"},{"issue":"8","key":"9_CR83","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/ng.2332","volume":"44","author":"MJ Lindhurst","year":"2012","unstructured":"Lindhurst MJ, Parker VER, Payne F, Sapp JC, Rudge S, Harris J et al (2012) Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA. Nat Genet 44(8):928\u2013933","journal-title":"Nat Genet"},{"issue":"8","key":"9_CR84","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/ng.2331","volume":"44","author":"J-B Rivi\u00e8re","year":"2012","unstructured":"Rivi\u00e8re J-B, Mirzaa GM, O\u2019Roak BJ, Beddaoui M, Alcantara D, Conway RL et al (2012) De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat Genet 44(8):934\u2013940","journal-title":"Nat Genet"},{"issue":"4","key":"9_CR85","doi-asserted-by":"publisher","first-page":"1152.e10","DOI":"10.1016\/j.jaci.2017.03.026","volume":"140","author":"AJ Takeda","year":"2017","unstructured":"Takeda AJ, Zhang Y, Dornan GL, Siempelkamp BD, Jenkins ML, Matthews HF et al (2017) Novel PIK3CD mutations affecting N-terminal residues of p110\u03b4 cause activated PI3K\u03b4 syndrome (APDS) in humans. J Allergy Clin Immunol 140(4):1152.e10\u20131156.e10","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"9_CR86","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1073\/pnas.1617244114","volume":"114","author":"GL Dornan","year":"2017","unstructured":"Dornan GL, Siempelkamp BD, Jenkins ML, Vadas O, Lucas CL, Burke JE (2017) Conformational disruption of PI3K\u03b4 regulation by immunodeficiency mutations in PIK3CD and PIK3R1. Proc Natl Acad Sci U S A 114(8):1982\u20131987","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"9_CR87","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nri.2016.93","volume":"16","author":"CL Lucas","year":"2016","unstructured":"Lucas CL, Chandra A, Nejentsev S, Condliffe AM, Okkenhaug K (2016) PI3K\u03b4 and primary immunodeficiencies. Nat Rev Immunol 16(11):702\u2013714","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"9_CR88","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1172\/JCI75746","volume":"124","author":"M-C Deau","year":"2014","unstructured":"Deau M-C, Heurtier L, Frange P, Suarez F, Bole-Feysot C, Nitschke P et al (2014) A human immunodeficiency caused by mutations in the PIK3R1 gene. J Clin Invest 124(9):3923\u20133928","journal-title":"J Clin Invest"},{"issue":"6160","key":"9_CR89","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1126\/science.1243292","volume":"342","author":"I Angulo","year":"2013","unstructured":"Angulo I, Vadas O, Gar\u00e7on F, Banham-Hall E, Plagnol V, Leahy TR et al (2013) Phosphoinositide 3-kinase \u03b4 gene mutation predisposes to respiratory infection and airway damage. Science 342(6160):866\u2013871","journal-title":"Science"},{"issue":"13","key":"9_CR90","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1084\/jem.20141759","volume":"211","author":"CL Lucas","year":"2014","unstructured":"Lucas CL, Zhang Y, Venida A, Wang Y, Hughes J, McElwee J et al (2014) Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K. J Exp Med 211(13):2537\u20132547","journal-title":"J Exp Med"},{"issue":"1","key":"9_CR91","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ni.2771","volume":"15","author":"CL Lucas","year":"2014","unstructured":"Lucas CL, Kuehn HS, Zhao F, Niemela JE, Deenick EK, Palendira U et al (2014) Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110\u03b4 result in T cell senescence and human immunodeficiency. Nat Immunol 15(1):88\u201397","journal-title":"Nat Immunol"},{"key":"9_CR92","doi-asserted-by":"crossref","unstructured":"Ali K, Soond DR, Pi\u00f1eiro R, Hagemann T, Pearce W, Lim EL et al (2014) Inactivation of PI(3)K p110\u03b4 breaks regulatory T-cell-mediated immune tolerance to cancer. Nature 11","DOI":"10.1038\/nature13444"},{"issue":"7629","key":"9_CR93","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nature19834","volume":"539","author":"MM Kaneda","year":"2016","unstructured":"Kaneda MM, Messer KS, Ralainirina N, Li H, Leem CJ, Gorjestani S et al (2016) PI3K\u03b3 is a molecular switch that controls immune suppression. Nature 539(7629):437\u2013442","journal-title":"Nature"},{"issue":"7629","key":"9_CR94","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature20554","volume":"539","author":"O De Henau","year":"2016","unstructured":"De Henau O, Rausch M, Winkler D, Campesato LF, Liu C, Cymerman DH et al (2016) Overcoming resistance to checkpoint blockade therapy by targeting PI3K\u03b3 in myeloid cells. Nature 539(7629):443\u2013447","journal-title":"Nature"},{"issue":"488","key":"9_CR95","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aaf2969","volume":"10","author":"L Breasson","year":"2017","unstructured":"Breasson L, Becattini B, Sardi C, Molinaro A, Zani F, Marone R et al (2017) PI3K\u03b3 activity in leukocytes promotes adipose tissue inflammation and early-onset insulin resistance during obesity. Sci Signal 10(488):eaaf2969","journal-title":"Sci Signal"},{"issue":"9","key":"9_CR96","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/nm1284","volume":"11","author":"M Camps","year":"2005","unstructured":"Camps M, R\u00fcckle T, Ji H, Ardissone V, Rintelen F, Shaw J et al (2005) Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 11(9):936\u2013943","journal-title":"Nat Med"},{"issue":"7719","key":"9_CR97","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41586-018-0343-4","volume":"560","author":"BD Hopkins","year":"2018","unstructured":"Hopkins BD, Pauli C, Du X, Wang DG, Li X, Wu D et al (2018) Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature 560(7719):499\u2013503","journal-title":"Nature"},{"issue":"1","key":"9_CR98","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ajhg.2013.05.019","volume":"93","author":"C Thauvin-Robinet","year":"2013","unstructured":"Thauvin-Robinet C, Auclair M, Duplomb L, Caron-Debarle M, Avila M, St-Onge J et al (2013) PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy. Am J Hum Genet 93(1):141\u2013149","journal-title":"Am J Hum Genet"},{"issue":"1","key":"9_CR99","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ajhg.2013.06.005","volume":"93","author":"DA Dyment","year":"2013","unstructured":"Dyment DA, Smith AC, Alcantara D, Schwartzentruber JA, Basel-Vanagaite L, Curry CJ et al (2013) Mutations in PIK3R1 cause SHORT syndrome. Am J Hum Genet 93(1):158\u2013166","journal-title":"Am J Hum Genet"},{"issue":"1","key":"9_CR100","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ajhg.2013.05.023","volume":"93","author":"KK Chudasama","year":"2013","unstructured":"Chudasama KK, Winnay J, Johansson S, Claudi T, K\u00f6nig R, Haldorsen I et al (2013) SHORT syndrome with partial lipodystrophy due to impaired phosphatidylinositol 3 kinase signaling. Am J Hum Genet 93(1):150\u2013157","journal-title":"Am J Hum Genet"},{"key":"9_CR101","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1056\/NEJMra1704560","volume":"379","author":"MD Goncalves","year":"2018","unstructured":"Goncalves MD, Cantley LC (2018) Phosphatidylinositol 3-kinase, growth disorders, and cancer. N Engl J Med 379:2052\u20132062","journal-title":"N Engl J Med"},{"issue":"10","key":"9_CR102","doi-asserted-by":"publisher","first-page":"4815","DOI":"10.1021\/acs.jmedchem.8b01492","volume":"62","author":"AE Garces","year":"2019","unstructured":"Garces AE, Stocks MJ (2019) Class 1 PI3K clinical candidates and recent inhibitor design strategies: a medicinal chemistry perspective. J Med Chem 62(10):4815\u20134850","journal-title":"J Med Chem"},{"issue":"3","key":"9_CR103","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/biom9030082","volume":"9","author":"MS Miller","year":"2019","unstructured":"Miller MS, Thompson PE, Gabelli SB (2019) Structural determinants of isoform selectivity in PI3K inhibitors. Biomolecules 9(3):82","journal-title":"Biomolecules"},{"issue":"11","key":"9_CR104","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1158\/1535-7163.MCT-12-0993-T","volume":"12","author":"N Liu","year":"2013","unstructured":"Liu N, Rowley BR, Bull CO, Schneider C, Haegebarth A, Schatz CA et al (2013) BAY 80\u20136946 is a highly selective intravenous PI3K inhibitor with potent p110\u03b1 and p110\u03b4 activities in tumor cell lines and xenograft models. Mol Cancer Ther 12(11):2319\u20132330","journal-title":"Mol Cancer Ther"},{"issue":"14","key":"9_CR105","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/cmdc.201600148","volume":"11","author":"WJ Scott","year":"2016","unstructured":"Scott WJ, Hentemann MF, Rowley RB, Bull CO, Jenkins S, Bullion AM et al (2016) Discovery and SAR of novel 2,3-Dihydroimidazo[1,2-c]quinazoline PI3K inhibitors: identification of Copanlisib (BAY 80-6946). ChemMedChem 11(14):1517\u20131530","journal-title":"ChemMedChem"},{"issue":"10","key":"9_CR106","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1021\/ml200156t","volume":"2","author":"MT Burger","year":"2011","unstructured":"Burger MT, Pecchi S, Wagman A, Ni Z-J, Knapp M, Hendrickson T et al (2011) Identification of NVP-BKM120 as a potent, selective, orally bioavailable class I PI3 kinase inhibitor for treating cancer. ACS Med Chem Lett 2(10):774\u2013779","journal-title":"ACS Med Chem Lett"},{"issue":"18","key":"9_CR107","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.1021\/jm800295d","volume":"51","author":"AJ Folkes","year":"2008","unstructured":"Folkes AJ, Ahmadi K, Alderton WK, Alix S, Baker SJ, Box G et al (2008) The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer. J Med Chem 51(18):5522\u20135532","journal-title":"J Med Chem"},{"key":"9_CR108","doi-asserted-by":"publisher","first-page":"14683","DOI":"10.1038\/ncomms14683","volume":"8","author":"T Bohnacker","year":"2017","unstructured":"Bohnacker T, Prota AE, Beaufils F, Burke JE, Melone A, Inglis AJ et al (2017) Deconvolution of Buparlisib\u2019s mechanism of action defines specific PI3K and tubulin inhibitors for therapeutic intervention. Nat Commun 8:14683","journal-title":"Nat Commun"},{"issue":"17","key":"9_CR109","doi-asserted-by":"publisher","first-page":"7524","DOI":"10.1021\/acs.jmedchem.7b00930","volume":"60","author":"F Beaufils","year":"2017","unstructured":"Beaufils F, Cmiljanovic N, Cmiljanovic V, Bohnacker T, Melone A, Marone R et al (2017) 5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a potent, brain-penetrant, orally bioavailable, Pan-class I PI3K\/mTOR inhibitor as clinical candidate in oncology. J Med Chem 60(17):7524\u20137538","journal-title":"J Med Chem"},{"key":"9_CR110","first-page":"1346","volume":"26","author":"F Janku","year":"2018","unstructured":"Janku F, Yap TA, Meric-Bernstam F (2018) Targeting the PI3K pathway in cancer: are we making headway? Nat Rev Clin Oncol 26:1346","journal-title":"Nat Rev Clin Oncol"},{"issue":"20","key":"9_CR111","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1056\/NEJMoa1813904","volume":"380","author":"F Andr\u00e9","year":"2019","unstructured":"Andr\u00e9 F, Ciruelos E, Rubovszky G, Campone M, Loibl S, Rugo HS et al (2019) Alpelisib for PIK3CA-mutated, hormone receptor-positive advanced breast cancer. N Engl J Med 380(20):1929\u20131940","journal-title":"N Engl J Med"},{"key":"9_CR112","first-page":"195","volume":"13","author":"Q Venot","year":"2018","unstructured":"Venot Q, Blanc T, Rabia SH, Berteloot L, Ladraa S, Duong J-P et al (2018) Targeted therapy in patients with PIK3CA-related overgrowth syndrome. Nature 13:195","journal-title":"Nature"},{"issue":"13","key":"9_CR113","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1016\/j.bmcl.2013.05.007","volume":"23","author":"P Furet","year":"2013","unstructured":"Furet P, Guagnano V, Fairhurst RA, Imbach-Weese P, Bruce I, Knapp M et al (2013) Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation. Bioorg Med Chem Lett 23(13):3741\u20133748","journal-title":"Bioorg Med Chem Lett"},{"issue":"13","key":"9_CR114","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1016\/j.bmcl.2017.05.028","volume":"27","author":"B Barlaam","year":"2017","unstructured":"Barlaam B, Cosulich S, Fitzek M, Germain H, Green S, Hanson LL et al (2017) Discovery of a novel aminopyrazine series as selective PI3K\u03b1 inhibitors. Bioorg Med Chem Lett 27(13):3030\u20133035","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"9_CR115","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.bmc.2018.02.015","volume":"26","author":"Y-H Fan","year":"2018","unstructured":"Fan Y-H, Ding H-W, Liu D-D, Song H-R, Xu Y-N, Wang J (2018) Novel 4-aminoquinazoline derivatives induce growth inhibition, cell cycle arrest and apoptosis via PI3K\u03b1 inhibition. Bioorg Med Chem 26(8):1675\u20131685","journal-title":"Bioorg Med Chem"},{"issue":"3","key":"9_CR116","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1021\/acs.jmedchem.5b01483","volume":"59","author":"TP Heffron","year":"2016","unstructured":"Heffron TP, Heald RA, Ndubaku C, Wei B, Augistin M, Do S et al (2016) The rational design of selective benzoxazepin inhibitors of the \u03b1-isoform of phosphoinositide 3-kinase culminating in the identification of (S)-2-((2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)oxy)propanamide (GDC-0326). J Med Chem 59(3):985\u20131002","journal-title":"J Med Chem"},{"issue":"3","key":"9_CR117","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1021\/jm3008745","volume":"56","author":"M Nacht","year":"2013","unstructured":"Nacht M, Qiao L, Sheets MP, St Martin T, Labenski M, Mazdiyasni H et al (2013) Discovery of a potent and isoform-selective targeted covalent inhibitor of the lipid kinase PI3K\u03b1. J Med Chem 56(3):712\u2013721","journal-title":"J Med Chem"},{"issue":"2","key":"9_CR118","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1182\/blood-2010-03-275305","volume":"117","author":"BJ Lannutti","year":"2011","unstructured":"Lannutti BJ, Meadows SA, Herman SEM, Kashishian A, Steiner B, Johnson AJ et al (2011) CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability. Blood 117(2):591\u2013594","journal-title":"Blood"},{"issue":"11","key":"9_CR119","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1056\/NEJMoa1314583","volume":"370","author":"AK Gopal","year":"2014","unstructured":"Gopal AK, Kahl BS, de Vos S, Wagner-Johnston ND, Schuster SJ, Jurczak WJ et al (2014) PI3K\u03b4 inhibition by idelalisib in patients with relapsed indolent lymphoma. N Engl J Med 370(11):1008\u20131018","journal-title":"N Engl J Med"},{"issue":"13","key":"9_CR120","doi-asserted-by":"publisher","first-page":"8439","DOI":"10.1074\/jbc.M114.634683","volume":"290","author":"JR Somoza","year":"2015","unstructured":"Somoza JR, Koditek D, Villase\u00f1or AG, Novikov N, Wong MH, Liclican A et al (2015) Structural, biochemical, and biophysical characterization of idelalisib binding to phosphoinositide 3-kinase \u03b4. J Biol Chem 290(13):8439\u20138446","journal-title":"J Biol Chem"},{"issue":"1","key":"9_CR121","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1021\/jm501624r","volume":"58","author":"TD Cushing","year":"2015","unstructured":"Cushing TD, Hao X, Shin Y, Andrews K, Brown M, Cardozo M et al (2015) Discovery and in vivo evaluation of (S)-N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (AMG319) and related PI3K\u03b4 inhibitors for inflammation and autoimmune disease. J Med Chem 58(1):480\u2013511","journal-title":"J Med Chem"},{"issue":"9","key":"9_CR122","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1021\/acsmedchemlett.7b00293","volume":"8","author":"K Hoegenauer","year":"2017","unstructured":"Hoegenauer K, Soldermann N, Z\u00e9cri F, Strang RS, Graveleau N, Wolf RM et al (2017) Discovery of CDZ173 (Leniolisib), representing a structurally novel class of PI3K delta-selective inhibitors. ACS Med Chem Lett 8(9):975\u2013980","journal-title":"ACS Med Chem Lett"},{"issue":"21","key":"9_CR123","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1182\/blood-2017-08-801191","volume":"130","author":"VK Rao","year":"2017","unstructured":"Rao VK, Webster S, Dalm VASH, Sediva A, van Hagen PM, Holland S et al (2017) Effective \u201cActivated PI3K\u03b4 syndrome-\u201dtargeted therapy with the PI3K\u03b4 inhibitor leniolisib. Blood 130(21):2307\u20132316","journal-title":"Blood"},{"issue":"11","key":"9_CR124","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.chembiol.2013.09.017","volume":"20","author":"DG Winkler","year":"2013","unstructured":"Winkler DG, Faia KL, DiNitto JP, Ali JA, White KF, Brophy EE et al (2013) PI3K-\u03b4 and PI3K-\u03b3 inhibition by IPI-145 abrogates immune responses and suppresses activity in autoimmune and inflammatory disease models. Chem Biol 20(11):1364\u20131374","journal-title":"Chem Biol"},{"issue":"9","key":"9_CR125","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1021\/acsmedchemlett.6b00238","volume":"7","author":"CA Evans","year":"2016","unstructured":"Evans CA, Liu T, Lescarbeau A, Nair SJ, Grenier L, Pradeilles JA et al (2016) Discovery of a selective phosphoinositide-3-kinase (PI3K)-\u03b3 inhibitor (IPI-549) as an immuno-oncology clinical candidate. ACS Med Chem Lett 7(9):862\u2013867","journal-title":"ACS Med Chem Lett"},{"issue":"4","key":"9_CR126","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41589-018-0215-0","volume":"15","author":"G Gangadhara","year":"2019","unstructured":"Gangadhara G, Dahl G, Bohnacker T, Rae R, Gunnarsson J, Blaho S et al (2019) A class of highly selective inhibitors bind to an active state of PI3K\u03b3. Nat Chem Biol 15(4):348\u2013357","journal-title":"Nat Chem Biol"},{"key":"9_CR127","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.meegid.2012.10.016","volume":"14","author":"C Tapparel","year":"2013","unstructured":"Tapparel C, Siegrist F, Petty TJ, Kaiser L (2013) Picornavirus and enterovirus diversity with associated human diseases. Infect Genet Evol 14:282\u2013293","journal-title":"Infect Genet Evol"},{"issue":"6264","key":"9_CR128","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1126\/science.aac7557","volume":"350","author":"VA Blomen","year":"2015","unstructured":"Blomen VA, M\u00e1jek P, Jae LT, Bigenzahn JW, Nieuwenhuis J, Staring J et al (2015) Gene essentiality and synthetic lethality in haploid human cells. Science 350(6264):1092\u20131096","journal-title":"Science"},{"issue":"3","key":"9_CR129","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.chom.2013.08.002","volume":"14","author":"O Ilnytska","year":"2013","unstructured":"Ilnytska O, Santiana M, Hsu N-Y, Du W-L, Chen Y-H, Viktorova EG et al (2013) Enteroviruses harness the cellular endocytic machinery to remodel the host cell cholesterol landscape for effective viral replication. Cell Host Microbe 14(3):281\u2013293","journal-title":"Cell Host Microbe"},{"issue":"10","key":"9_CR130","doi-asserted-by":"publisher","first-page":"5149","DOI":"10.1128\/AAC.00946-12","volume":"56","author":"MJ Lamarche","year":"2012","unstructured":"Lamarche MJ, Borawski J, Bose A, Capacci-Daniel C, Colvin R, Dennehy M et al (2012) Anti-hepatitis C virus activity and toxicity of type III phosphatidylinositol-4-kinase beta inhibitors. Antimicrob Agents Chemother 56(10):5149\u20135156","journal-title":"Antimicrob Agents Chemother"},{"issue":"15","key":"9_CR131","doi-asserted-by":"publisher","first-page":"6705","DOI":"10.1021\/acs.jmedchem.8b00521","volume":"61","author":"J Reuberson","year":"2018","unstructured":"Reuberson J, Horsley H, Franklin RJ, Ford D, Neuss J, Brookings D et al (2018) Discovery of a potent, orally bioavailable PI4KIII\u03b2 inhibitor (UCB9608) able to significantly prolong allogeneic organ engraftment in vivo. J Med Chem 61(15):6705\u20136723","journal-title":"J Med Chem"},{"issue":"5","key":"9_CR132","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1021\/acs.jmedchem.5b01311","volume":"59","author":"FU Rutaganira","year":"2016","unstructured":"Rutaganira FU, Fowler ML, McPhail JA, Gelman MA, Nguyen K, Xiong A et al (2016) Design and structural characterization of potent and selective inhibitors of phosphatidylinositol 4 kinase III\u03b2. J Med Chem 59(5):1830\u20131839","journal-title":"J Med Chem"},{"issue":"1","key":"9_CR133","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1021\/acs.jmedchem.6b01465","volume":"60","author":"I Mejdrov\u00e1","year":"2017","unstructured":"Mejdrov\u00e1 I, Chalupsk\u00e1 D, Pla\u010dkov\u00e1 P, M\u00fcller C, \u0160\u00e1la M, Klima M et al (2017) Rational design of novel highly potent and selective phosphatidylinositol 4-kinase III\u03b2 (PI4KB) inhibitors as broad-spectrum antiviral agents and tools for chemical biology. J Med Chem 60(1):100\u2013118","journal-title":"J Med Chem"},{"issue":"5","key":"9_CR134","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1128\/JVI.02249-10","volume":"85","author":"M Arita","year":"2011","unstructured":"Arita M, Kojima H, Nagano T, Okabe T, Wakita T, Shimizu H (2011) Phosphatidylinositol 4-kinase III beta is a target of enviroxime-like compounds for antipoliovirus activity. J Virol 85(5):2364\u20132372","journal-title":"J Virol"},{"issue":"5","key":"9_CR135","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S et al (2014) Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 371(5):411\u2013423","journal-title":"N Engl J Med"},{"issue":"3","key":"9_CR136","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.ejmech.2008.08.011","volume":"44","author":"N Vale","year":"2009","unstructured":"Vale N, Moreira R, Gomes P (2009) Primaquine revisited six decades after its discovery. Eur J Med Chem 44(3):937\u2013953","journal-title":"Eur J Med Chem"},{"issue":"7","key":"9_CR137","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1128\/EC.00107-07","volume":"6","author":"MJ Rodgers","year":"2007","unstructured":"Rodgers MJ, Albanesi JP, Phillips MA (2007) Phosphatidylinositol 4-kinase III-beta is required for Golgi maintenance and cytokinesis in Trypanosoma brucei. Eukaryot Cell 6(7):1108\u20131118","journal-title":"Eukaryot Cell"},{"issue":"7","key":"9_CR138","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1021\/jm3001373","volume":"55","author":"Y Younis","year":"2012","unstructured":"Younis Y, Douelle F, Feng T-S, Gonz\u00e1lez Cabrera D, Le Manach C, Nchinda AT et al (2012) 3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential. J Med Chem 55(7):3479\u20133487","journal-title":"J Med Chem"},{"issue":"9","key":"9_CR139","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1128\/AAC.00012-18","volume":"62","author":"C Brunschwig","year":"2018","unstructured":"Brunschwig C, Lawrence N, Taylor D, Abay E, Njoroge M, Basarab GS et al (2018) UCT943, a next-generation Plasmodium falciparum PI4K inhibitor preclinical candidate for the treatment of malaria. Antimicrob Agents Chemother 62(9):62","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"9_CR140","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/pro.2879","volume":"25","author":"ML Fowler","year":"2016","unstructured":"Fowler ML, McPhail JA, Jenkins ML, Masson GR, Rutaganira FU, Shokat KM et al (2016) Using hydrogen deuterium exchange mass spectrometry to engineer optimized constructs for crystallization of protein complexes: case study of PI4KIII\u03b2 with Rab11. Protein Sci 25(4):826\u2013839","journal-title":"Protein Sci"},{"issue":"W1","key":"9_CR141","doi-asserted-by":"publisher","first-page":"W320","DOI":"10.1093\/nar\/gku316","volume":"42","author":"X Robert","year":"2014","unstructured":"Robert X, Gouet P (2014) Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res 42(W1):W320\u2013W324","journal-title":"Nucleic Acids Res"}],"container-title":["Advances in Experimental Medicine and Biology","Druggable Lipid Signaling Pathways"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-50621-6_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T06:06:51Z","timestamp":1649830011000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-50621-6_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030506209","9783030506216"],"references-count":141,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-50621-6_9","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"8 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}